Examination of the early clinical and endoscopic views change after infliximab administration in the ulcerative colitis.
Not Applicable
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000013033
- Lead Sponsor
- Department of Internal Medicine,Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patients with serious infection (sepsis) 2. The patients with active tuberculosis 3. The patients with a history of sensitivity to protein(mouse type, a chimeric type, humanized antibody) derived from a mouse or ingredient of the Infliximab 4. The patients with a history of demyelinating diseases (Multiple sclerosis) 5. The patients with congestive heart failure 6. The patients that doctor attending judged an arrangement to this study to be inappropriate
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method